Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

References

• SeufferleinTBachetJBVan CutsemERougierPGroup EGWPancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201223Suppl 7vii33vii4022997452
   PubMed Web of Science ®Google Scholar
• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• ZengHZhengRGuoYCancer survival in China, 2003–2005: a population-based studyInt J Cancer201513681921193025242378
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• ChitkaraDMittalAMahatoRImiRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategiesAdv Drug Deliv Rev201581345225252098
   PubMed Web of Science ®Google Scholar
• RachaganiSMachaMAHeimannNClinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancerAdv Drug Deliv Rev201581163325453266
   PubMed Web of Science ®Google Scholar
• CostelloEGreenhalfWNeoptolemosJPNew biomarkers and targets in pancreatic cancer and their application to treatmentNat Rev Gas-troenterol Hepatol201298435444
   PubMed Web of Science ®Google Scholar
• WaldPLiuXSPettitCPrognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literatureOncotarget2017842733457336129069873
   PubMedGoogle Scholar
• TomczakKCzerwinskaPWiznerowiczMThe Cancer Genome Atlas (TCGA): an immeasurable source of knowledgeContemp Oncol2015191AA68A77
   Google Scholar
• Cancer Genome Atlas Research NetworkWeinsteinJNCollissonEAThe Cancer Genome Atlas Pan-Cancer analysis projectNat Genet201345101113112024071849
   PubMed Web of Science ®Google Scholar
• LiaoXHuangKHuangRGenome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyOnco Targets Ther2017104493450628979141
   PubMed Web of Science ®Google Scholar
• LiaoXHuangRLiuXDistinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinomaOnco Targets Ther2017103719373228769575
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkIntegrated genomic characterization of pancreatic ductal adenocarcinomaCancer Cell2017322185203.e11328810144
   PubMed Web of Science ®Google Scholar
• AndersSHuberWDifferential expression analysis for sequence count dataGenom Biol20101110R106
   PubMed Web of Science ®Google Scholar
• HuangRLiaoXLiQIdentification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemiaOnco Targets Ther2017105243525429138577
   PubMed Web of Science ®Google Scholar
• LiaoXZhuGHuangRIdentification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinomaCancer Manag Res20181078780329713196
   PubMed Web of Science ®Google Scholar
• AgarwalVBellGWNamJWBartelDPPredicting effective microRNA target sites in mammalian mRNAseLife20154
   Web of Science ®Google Scholar
• LewisBPBurgeCBBartelDPConserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targetsCell20051201152015652477
   PubMed Web of Science ®Google Scholar
• WangXImproving microRNA target prediction by modeling with unambiguously identified microRNA-target pairs from CLIP-ligation studiesBioinformatics20163291316132226743510
   PubMed Web of Science ®Google Scholar
• WongNWangXmiRDB: an online resource for microRNA target prediction and functional annotationsNucleic Acids Res201543Database issueD146D15225378301
   PubMed Web of Science ®Google Scholar
• ChouCHShresthaSYangCDmiRTarBase update 2018: a resource for experimentally validated microRNA-target interactionsNucleic Acids Res201846D1D296D30229126174
   PubMed Web of Science ®Google Scholar
• HsuSDLinFMWuWYmiRTarBase: a database curates experimentally validated microRNA-target interactionsNucleic Acids Res201139Database issueD163D16921071411
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRABioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Res200937111319033363
   PubMed Web of Science ®Google Scholar
• BenjaminiYHochbergYControlling the false discovery rate: a practical and powerful approach to multiple testingJ Royal Stat Society Series B1995571289300
   Google Scholar
• ReinerAYekutieliDBenjaminiYIdentifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics200319336837512584122
   PubMed Web of Science ®Google Scholar
• BenjaminiYDraiDElmerGKafkafiNGolaniIControlling the false discovery rate in behavior genetics researchBehav Brain Res20011251–227928411682119
   PubMed Web of Science ®Google Scholar
• ZhouXHuangZXuLA panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancerOncotarget2016743696166962427626307
   PubMedGoogle Scholar
• LiangLWeiDMLiJJPrognostic microRNAs and their potential molecular mechanism in pancreatic cancer: a study based on The Cancer Genome Atlas and bioinformatics investigationMol Med Reports2018171939951
   PubMed Web of Science ®Google Scholar
• Mino-KenudsonMFernandez-del CastilloCBabaYPrognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypesGut201160121712172021508421
   PubMed Web of Science ®Google Scholar
• StotzMEisnerFSzkanderaJClinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European seriesJ Clin Pathol201366975375723750038
   PubMed Web of Science ®Google Scholar
• CuillerierECellierCPalazzoLOutcome after surgical resection of intraductal papillary and mucinous tumors of the pancreasAm J Gastroenterol200095244144510685747
   PubMed Web of Science ®Google Scholar
• LingQXuXYePThe prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinomaOncotarget201789151591516728122349
   PubMedGoogle Scholar
• HuangDHWangGYZhangJWLiYZengXCJiangNMiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinomaJpn J Clin Oncol201545873874425917358
   PubMed Web of Science ®Google Scholar
• FanDRenBYangXLiuJZhangZUpregulation of miR-501-5p activates the wnt/beta-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancerJ Exp Clin Cancer Res201635117727846906
   PubMedGoogle Scholar
• SandMSkryganMSandDComparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic neviCell Tissue Res20133511859823111773
   PubMed Web of Science ®Google Scholar
• FengSDMaoZLiuCSimultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinomaOnco Targets Ther2017105591560429200874
   PubMed Web of Science ®Google Scholar
• LiuSGQinXGZhaoBSDifferential expression of miRNAs in esophageal cancer tissueOncol Lett2013551639164223761828
   PubMed Web of Science ®Google Scholar
• QianYWangXLvZMicroRNA126 is downregulated in thyroid cancer cells, and regulates proliferation, migration and invasion by targeting CXCR4Mol Med Rep201614145345927175968
   PubMed Web of Science ®Google Scholar
• ZhangGMLuoLDingXMMicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinomaMol Med Rep20161365029203627108693
   PubMed Web of Science ®Google Scholar
• DebernardiSMassatNJRadonTPNoninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinomaAm J Cancer Res20155113455346626807325
   PubMed Web of Science ®Google Scholar
• BhattacharyaSSteeleRShrivastavaSChakrabortySDi BisceglieAMRayRBSerum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinomaAm J Pathol2016186224224726776075
   PubMed Web of Science ®Google Scholar
• SilvaJGarciaVZaballosAVesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survivalEur Respir J201137361762320595154
   PubMed Web of Science ®Google Scholar
• MarkouASourvinouIVorkasPAYousefGMLianidouEClinical evaluation of microRNA expression profiling in non small cell lung cancerLung Cancer201381338839623756108
   PubMed Web of Science ®Google Scholar
• HuYCorreaAMHoqueAPrognostic significance of differentially expressed miRNAs in esophageal cancerInt J Cancer2011128113214320309880
   PubMed Web of Science ®Google Scholar
• LeeHParkCSDeftereosGMicroRNA expression in ovarian carcinoma and its correlation with clinicopathological featuresWorld J Surg Oncol20121017422925189
   PubMed Web of Science ®Google Scholar
• D’AiutoFCallariMDugoMmiR-30e* is an independent subtype-specific prognostic marker in breast cancerBr J Cancer2015113229029826057454
   PubMed Web of Science ®Google Scholar
• KoYCFangWHLinTCMicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemiaLeuk Res201438562563124703161
   PubMed Web of Science ®Google Scholar
• LuLKatsarosDZhuYLet-7a regulation of insulin-like growth factors in breast cancerBreast Cancer Res Treat2011126368769420848182
   PubMed Web of Science ®Google Scholar
• LuLKatsarosDde la LongraisIASochircaOYuHHypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosisCancer Res20076721101171012217974952
   PubMed Web of Science ®Google Scholar
• LiYLinJYangJOverexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemiaLeuk Res201337121642164724138945
   PubMed Web of Science ®Google Scholar
• JiangZGuoJXiaoBIncreased expression of miR-421 in human gastric carcinoma and its clinical associationJ Gastroenterol2010451172319802518
   PubMed Web of Science ®Google Scholar
• GeXLiuXLinFMicroRNA-421 regulated by HIF-1alpha promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancerOncotarget2016717244662448227016414
   PubMed Web of Science ®Google Scholar
• ZhaoGXuLHuiLZhaoJLevel of circulated microRNA-421 in gastric carcinoma and related mechanismsInt J Clin Exp Pathol2015811142521425626823741
   PubMed Web of Science ®Google Scholar
• ZhangYGongWDaiSDownregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cellsMol Cancer Res201210451652222446874
   PubMed Web of Science ®Google Scholar
• LuMKongXWangHHuangGYeCHeZA novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosisOncotarget2017858775878428060739
   PubMedGoogle Scholar
• HaoJZhangSZhouYLiuCHuXShaoCMicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancerBiochem Biophys Res Commun2011406455255721352803
   PubMed Web of Science ®Google Scholar
• ZhongXYYuJHZhangWGMicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expressionGene20124931445122146319
   PubMed Web of Science ®Google Scholar
• ZhouSWangBHuJmiR-421 is a diagnostic and prognostic marker in patients with osteosarcomaTumour Biol20163779001900726758431
   PubMedGoogle Scholar
• ChenLTangYWangJYanZXuRmiR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4Biochem Biophys Res Commun2013435474575023707940
   PubMed Web of Science ®Google Scholar
• LiuHGaoYSongDLiuTFengYCorrelation between microRNA-421 expression level and prognosis of gastric cancerInt J Clin Exp Pathol2015811151281513226823855
   PubMed Web of Science ®Google Scholar
• MengDYangSWanXA transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cellsInt J Biochem Cell Biol201673304026827675
   PubMed Web of Science ®Google Scholar
• Champeris TsanirasSKanellakisNSymeonidouIENikolopoulouPLygerouZTaravirasSLicensing of DNA replication, cancer, pluripotency and differentiation: an interlinked world?Semin Cell Dev Biol20143017418024641889
   PubMed Web of Science ®Google Scholar
• RoySKSrivastavaRKShankarSInhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancerJ Mol Signal201051020642839
   PubMedGoogle Scholar
• CollinsMAYanWSebolt-LeopoldJSPasca di MaglianoMMAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in miceGastroenterology20141463822834.e82724315826
   PubMed Web of Science ®Google Scholar
• KopperFBinkowskiAMBierwirthCDobbelsteinMThe MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cellsCell Cycle201413688488924556918
   PubMed Web of Science ®Google Scholar
• GhasemiRRapposelliIGCaponeEDual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancerOncogenesis20143e11725133484
   PubMed Web of Science ®Google Scholar
• GrimontAPinhoAVCowleyMJSOX9 regulates ERBB signalling in pancreatic cancer developmentGut201564111790179925336113
   PubMed Web of Science ®Google Scholar
• DoiTIshikawaTOkayamaTThe JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell linesOncol Rep20173731545155428112370
   PubMed Web of Science ®Google Scholar
• ChenLZhouDLiuZCombination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathwayOncol Rep20183931081108929328487
   PubMed Web of Science ®Google Scholar